Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations by Choudhary, GS, Pellagatti, A, Agianian, B, Smith, MA, Bhagat, TD, Gordon-Mitchell, S, Sahu, S, Pandey, S, Shah, N, Aluri, S, Aggarwal, R, Aminov, S, Schwartz, L, Steeples, V, Booher, RN, Ramachandra, M, Samson, M, Carbajal, M, Pradhan, K, Bowman, TV, Pillai, MM, Will, B, Wickrema, A, Shastri, A, Bradley, RK, Martell, RE, Steidl, UG, Gavathiotis, E, Boultwood, J, Starczynowski, DT, Verma, A